Treatment for Malaria in Pregnant Women
Author Information
Author(s): Kalilani Linda, Mofolo Innocent, Chaponda Marjorie, Rogerson Stephen J., Alker Alisa P., Kwiek Jesse J., Meshnick Steven R.
Primary Institution: Department of Epidemiology, University of North Carolina, Chapel Hill, North Carolina, United States of America
Hypothesis
Can azithromycin or artesunate combined with sulfadoxine-pyrimethamine effectively treat malaria in pregnant women?
Conclusion
Both SP-artesunate and SP-azithromycin were found to be safe and effective for treating malaria in pregnant women.
Supporting Evidence
- The parasite clearance time was significantly faster in the SP-artesunate group.
- Recrudescent episodes of malaria were less frequent with SP-azithromycin and SP-artesunate compared to SP monotherapy.
- All treatment regimens were well tolerated with minimal adverse effects.
Takeaway
This study tested new malaria treatments for pregnant women and found that two combinations worked well and were safe.
Methodology
A randomized open-label clinical trial with 141 pregnant women assigned to three treatment groups.
Potential Biases
Potential bias due to lack of blinding for participants and study nurses.
Limitations
The small sample size limited the evaluation of effects on birth outcomes and maternal health.
Participant Demographics
Pregnant women aged 15-49 with uncomplicated Plasmodium falciparum malaria.
Statistical Information
P-Value
p<0.01
Confidence Interval
95% CI 0.06 to 0.63
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website